Cytosorbents Corp. (CTSO) Stock Price

CTSOStock

$0.36−59.45%52W

Market Cap$22.33M

P/E—

PEG Ratio—

Div yield—

Beta1.32

CTSO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-54.20%

Price vs S&P 500 (4W)-3.00%

VGM Score41.76

Book Value / Share (Quarterly)$0.04

P/TBV (Annual)15.00x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)2.23%

Cash Flow / Share (Quarterly)$-0.15

Price vs S&P 500 (YTD)-54.02%

Gross Margin (TTM)71.61%

Net Profit Margin (TTM)-48.94%

EPS (TTM)$-0.29

10-Day Avg Trading Volume0.12M

EPS Excl Extra (TTM)$-0.29

Revenue Growth (5Y)-2.00%

EPS (Annual)$-0.13

ROI (Annual)-36.32%

Gross Margin (Annual)71.48%

Net Profit Margin (5Y Avg)-62.45%

Cash / Share (Quarterly)$0.07

Revenue Growth QoQ (YoY)0.17%

ROA (Last FY)-18.56%

Revenue Growth TTM (YoY)8.64%

EBITD / Share (TTM)$-0.20

ROE (5Y Avg)-116.40%

Operating Margin (TTM)-36.24%

Cash Flow / Share (Annual)$-0.20

P/B Ratio10.38x

P/B Ratio (Quarterly)16.18x

Net Income / Employee (Annual)$-63,600

EV / Revenue (TTM)0.96x

Net Interest Coverage (TTM)-2.98x

ROA (TTM)-43.25%

EPS Incl Extra (Annual)$-0.13

Current Ratio (Annual)2.13x

Quick Ratio (Quarterly)0.47x

3-Month Avg Trading Volume0.13M

52-Week Price Return-59.45%

Revenue / Employee (TTM)$288,500

Tangible BV / Share (Quarterly)$0.04

P/S Ratio (Annual)0.61x

Asset Turnover (Annual)0.84x

52-Week High$1.04

Operating Margin (5Y Avg)-63.98%

EPS Excl Extra (Annual)$-0.13

CapEx CAGR (5Y)-21.81%

Tangible BV CAGR (5Y)-48.65%

26-Week Price Return-42.96%

Quick Ratio (Annual)1.42x

13-Week Price Return-19.52%

Total Debt / Equity (Annual)2.82x

Current Ratio (Quarterly)0.66x

Enterprise Value$35.60M

Revenue / Share Growth (5Y)-10.83%

Asset Turnover (TTM)0.88x

Book Value / Share Growth (5Y)-44.79%

Revenue / Employee (Annual)$287,300

Inventory Turnover (Annual)2.64x

Pretax Margin (Annual)-23.20%

Cash / Share (Annual)$0.10

3-Month Return Std Dev102.06%

Gross Margin (5Y Avg)67.33%

Net Income / Employee (TTM)$-141,200

ROE (Last FY)-138.88%

Net Interest Coverage (Annual)-2.63x

EPS Basic Excl Extra (Annual)$-0.13

Receivables Turnover (TTM)5.12x

Total Debt / Equity (Quarterly)7.73x

EPS Incl Extra (TTM)$-0.29

Receivables Turnover (Annual)4.99x

ROI (TTM)-51.93%

P/S Ratio (TTM)0.61x

Pretax Margin (5Y Avg)-65.04%

Revenue / Share (Annual)$0.60

Tangible BV / Share (Annual)$0.04

Price vs S&P 500 (52W)-77.76%

Year-to-Date Return-42.07%

5-Day Price Return2.83%

EPS Normalized (Annual)$-0.13

ROA (5Y Avg)-39.37%

Net Profit Margin (Annual)-22.12%

Month-to-Date Return2.58%

Cash Flow / Share (TTM)$-0.50

EBITD / Share (Annual)$-0.23

Operating Margin (Annual)-41.30%

LT Debt / Equity (Annual)2.82x

ROI (5Y Avg)-68.38%

LT Debt / Equity (Quarterly)4.70x

EPS Basic Excl Extra (TTM)$-0.29

P/TBV (Quarterly)15.00x

P/B Ratio (Annual)6.80x

Inventory Turnover (TTM)2.86x

Pretax Margin (TTM)-50.02%

Book Value / Share (Annual)$0.09

Price vs S&P 500 (13W)-22.32%

Beta1.32x

Revenue / Share (TTM)$0.59

ROE (TTM)-165.13%

52-Week Low$0.30

vGradeB

gGradeD

mGradeD

vgmGradeC

CTSO Earnings Surprise History

Q2 250.03est. -0.06

Q3 25-0.05est. -0.05

Q4 25-0.09est. -0.05

Q1 26-0.08est. -0.06

Q2 26-0.07est. -0.04

CTSO Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

2.17

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
CTSOCytosorbents Corp.	B	D	D	$0.36
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16

About Cytosorbents Corp.

CytoSorbents develops proprietary polymer adsorption technology to treat life-threatening conditions in intensive care and cardiac surgery. Its EU-approved flagship product, CytoSorb, functions as an extracorporeal cytokine absorber designed to reduce inflammation and prevent multiple organ failure in critical illnesses such as sepsis and trauma. The company generates revenue from product sales across Germany and the United States, supplemented by government grants, with distribution through direct sales and strategic partnerships.